Monthly Archives: March 2022

MediSys Health Network CEO Named to the Mayor’s Health Equity Task Force

Posted on by

On February 17, New York City Mayor Eric Adams announced the formation of his administration’s COVID-19 Recovery Roundtable and Health Equity Task Force. This task force was created to advise the administration on long-term, comprehensive policies around health equity and health access.

This roughly 40-person commission, unprecedented for its diversity, is comprised of a group of leaders from 11 different industries from across the city. One of those chosen to join this esteemed panel of leaders is MediSys (Jamaica and Flushing Hospital) President and CEO, Bruce J. Flanz.

Mr. Flanz, along with the other members of the COVID-19 Recovery Roundtable and Health Equity Task Force will meet monthly and focus their attention on continuing the city’s path to a speedy, effective, and equitable recovery from the COVID-19 pandemic as well as building a healthier and stronger city for all New Yorkers.

According to Mayor Adams, “We cannot build a just and prosperous recovery for all New Yorkers without bringing together and listening to experts and community leaders from across the city. The COVID-19 Recovery Roundtable and Health Equity Task Force brings not only the best minds together to build a speedy recovery, but a lasting one. I’m grateful to the members for bringing their time and ideas to the city as we work towards this shared goal.”

First Deputy Mayor Lorraine Grillo added, “I’m thrilled to have leaders from every corner of New York City as part of our COVID-19 Recovery Roundtable and Health Equity Taskforce. Thank you to everyone who has joined this effort, I’m looking forward to rolling up our sleeves and getting to work developing long term policies to guide our city through a just and equitable recovery.” 

Mr. Flanz stated, “I am extremely proud to serve on this task force and I commend Mayor Adams for addressing these important issues. Representing two Queens-based hospitals located at the epicenter of the COVID pandemic, I witnessed first-hand the devastating effects the pandemic had on our communities that already face many socio-economic challenges. I look forward to working with this diverse group of talented individuals to address these disparities and create a more equitable health system for all.”

All content of this newsletter is intended for general information purposes only and is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Please consult a medical professional before adopting any of the suggestions on this page. You must never disregard professional medical advice or delay seeking medical treatment based upon any content of this newsletter. PROMPTLY CONSULT YOUR PHYSICIAN OR CALL 911 IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY.

March is Bleeding Disorders Awareness Month

Posted on by

March is recognized as Bleeding Disorders Awareness Month. This observance raises awareness for bleeding disorders such as hemophilia.

Hemophilia is a genetic disorder which slows the blood clotting process. It is estimated that hemophilia occurs in 1 in every 5,000 male births in the United States.  The disorder very rarely develops in girls.

According to the Centers for Disease Control and Prevention, “Hemophilia is caused by a mutation or change, in one of the genes, that provides instructions for making the clotting factor proteins needed to form a blood clot. This change or mutation can prevent the clotting protein from working properly or to be missing altogether.”

Because people with hemophilia lack sufficient blood clotting proteins, this causes them to bleed longer than they normally should.  Bleeding can occur spontaneously or following an injury. Other common signs and symptoms that they may experience include:

  • Bleeding into the joints which can lead to swelling, tightness or pain (This most commonly affects the ankles, knees and elbows)
  • Bleeding from the mouth and gums
  • Bleeding after receiving vaccinations or injections
  • Blood in the urine or stool
  • Frequent and hard to stop nosebleeds
  • Bleeding into the skin (bruises)
  • Bleeding into soft tissue and muscle (hematomas)

A diagnosis of hemophilia is determined after blood has been tested to reveal a clotting-factor deficiency.  If it is found that the blood is not clotting as it should, tests known as factor assays are required to explore the cause.  In severe cases, the disorder can be diagnosed within the first year of a child’s life. People with a family history of hemophilia are encouraged to have their baby boys tested soon after birth.

One of the most common approaches for treating hemophilia is to replace the missing blood clotting factor. This treatment is administered through a tube placed in the vein. Other forms of treatment can include taking clot preserving medications, injecting the hormone Desmopressin (DDAVP), applying fibrin sealants and participating in physical therapy.

There are several measures that a person living with hemophilia can take to reduce the chances of injury or excessive bleeding.  The following are recommended: avoid taking blood-thinning medications, exercise regularly (contact sports should be avoided), practice good dental hygiene and avoid certain pain medications that can aggravate bleeding such as aspirin.

If you would like to schedule an appointment with a physician at Jamaica Hospital Medical Center, please call 718-206-7001.

All content of this newsletter is intended for general information purposes only and is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Please consult a medical professional before adopting any of the suggestions on this page. You must never disregard professional medical advice or delay seeking medical treatment based upon any content of this newsletter. PROMPTLY CONSULT YOUR PHYSICIAN OR CALL 911 IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY.